Streamex Corp. (STEX), a Nasdaq-listed real-world asset (RWA) tokenization company formerly known as BioSig Technologies, has seen its share price collapse from above $5 within the past year to roughly $0.44. Against that backdrop, the question of whether the stock can climb back to the $4 mark—the only current, publicly discussed analyst price target—carries enormous implications for a company whose business model is still in its earliest stages.
Streamex does not have a meaningful multi-analyst consensus. Only one firm, Needham (analyst John Todaro), currently publishes a verified 12-month price target of $4.00 with a Buy rating, following a reduction from $8.00 on August 18, 2026. Roth Capital's Scott Henry has also historically covered the name, but no current, attributable target could be verified. Earlier targets of $12, $9, and $8 were all superseded as gold-token adoption disappointed. Because there are not multiple credible, current targets to average, the $4.00 figure is treated here as the single published objective being discussed publicly—not as an official consensus—and it is roughly nine times the current share price.
The latest verified price is approximately $0.44 as of the October 23, 2026 close, near the bottom of a 52-week range of roughly $0.35 to $5.26. Reaching $4.00 implies upside of about 800%, which must be described as a very large move. Streamex operates the Streamex Exchange, a blockchain platform designed to tokenize physical gold and gold-linked products such as the GLDY and GLDC tokens. The company recorded its first revenue and reported meaningful cost reductions in 2026, but trailing revenue remains roughly $146,000 against deep losses, and earnings per share (EPS) are still negative. The path to $4 would require not just renewed enthusiasm for gold and digital assets, but demonstrable growth in token issuance, assets under management, and revenue.
Streamex's bull case rests on its repositioning into asset tokenization at a time when institutional interest in gold-backed digital assets is rising. Management has highlighted a gold-denominated treasury, no material debt, custody and attestation partnerships, and 24/7 liquidity as foundational steps. A meaningful institutional allocation or acceleration in GLDY uptake could materially change the growth trajectory, and a sustained rally in gold prices or broader RWA-tokenization sentiment could lift investor interest in a stock that is deeply depressed from prior highs.
The risks are substantial and well documented. SEC filings include a going-concern warning, citing recurring losses and negative operating cash flow, and note the possibility of failing to maintain its Nasdaq Capital Market listing. Revenue is negligible relative to the company's roughly $80–100 million market capitalization, and the Q2 2026 report missed EPS and EBITDA expectations, prompting Needham's target cut. Any further delays in token adoption, additional dilution, or regulatory scrutiny of tokenized products could push the stock lower rather than higher.
The stock trades well below both its 200-day and 20-day moving averages after a sustained decline, signaling a firmly negative longer-term trend. The 52-week low near $0.35 is the most immediate support level, while prior trading zones around $1 (seen in early-to-mid 2026) represent notable overhead resistance. The $4 level itself sits within a range the stock occupied in late 2025, meaning the target is not without historical precedent, but reclaiming it would require reversing more than a year of technical deterioration.
Analyst price targets generally reflect a roughly 12-month research horizon, though with a single covering firm there is no meaningful dispersion to assess. The next earnings report is expected in mid-November 2026. Investors should watch token adoption and AUM figures, any changes to the going-concern language in filings, Nasdaq listing compliance, gold price movements, and whether Needham or other firms revise targets as new data emerges. No definitive forecast should be drawn from a single target.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on shifting market conditions, technical behavior, and AI-driven analysis. For a highly volatile name like STEX, these signals can help traders discover opportunities, monitor positions, and spot changing trends more efficiently than manual chart review alone. Explore the AI Daily Buy/Sell Signals to see how automated analysis can complement your own research.
Whether STEX can reach $4 hinges on a roughly 800% move that only one current analyst target envisions. The supporting thesis—gold tokenization, first revenue, and institutional-grade infrastructure—is real but unproven, while the obstacles—a going-concern warning, minimal revenue, listing risk, and a firmly downtrending chart—are concrete and near-term. With essentially no analyst consensus to triangulate, investors should treat $4 as a single-firm aspirational objective, weigh it against the company's still-early-stage fundamentals, and monitor adoption metrics and upcoming earnings rather than treat any target as a forecast.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, STEX has been loosely correlated with KEEL. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if STEX jumps, then KEEL could also see price increases.
| Ticker / NAME | Correlation To STEX | 1D Price Change % | ||
|---|---|---|---|---|
| STEX | 100% | -8.60% | ||
| KEEL - STEX | 35% Loosely correlated | -2.55% | ||
| BTBT - STEX | 34% Loosely correlated | -7.38% | ||
| PWCM - STEX | 32% Poorly correlated | -12.32% | ||
| BMNR - STEX | 31% Poorly correlated | -2.85% | ||
| CLSK - STEX | 30% Poorly correlated | -4.92% | ||
More | ||||
| Ticker / NAME | Correlation To STEX | 1D Price Change % |
|---|---|---|
| STEX | 100% | -8.60% |
| Investment Banks/Brokers industry (94 stocks) | 15% Poorly correlated | +2.50% |